{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:09:07Z","timestamp":1792688947816,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007117","name":"Instituto de Investiga\u00e7\u00e3o Cient\u00edfica Tropical","doi-asserted-by":"publisher","award":["\/2025\/418"],"award-info":[{"award-number":["\/2025\/418"]}],"id":[{"id":"10.13039\/501100007117","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jchromb.2026.125182","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:01:19Z","timestamp":1781460079000},"page":"125182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Stability-indicating RP-HPLC\u2013DAD method for aspirin and vonoprazan using analytical quality by design and comprehensive greenness assessment"],"prefix":"10.1016","volume":"1281","author":[{"given":"Meghana","family":"Ajmeera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sravya","family":"Goli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Alegete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2026.125182_bb0005","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis, N","volume":"353","author":"Patrono","year":"2005","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.jchromb.2026.125182_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jchromb.2026.125182_bb0015","first-page":"91","article-title":"Aspirin, cyclooxygenase inhibition and colorectal cancer, world J. Gastrointest","volume":"4","author":"Sostres","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2026.125182_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.gtc.2009.03.007","article-title":"Nonsteroidal anti-inflammatory drugs and lower gastrointestinal complications","volume":"38","author":"Lanas","year":"2009","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.jchromb.2026.125182_bb0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/apt.13325","article-title":"Acid-inhibitory effects of vonoprazan fumarate compared with lansoprazole: a randomised, placebo-controlled, crossover study in healthy subjects","volume":"42","author":"Sakurai","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2026.125182_bb0030","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pharmthera.2005.05.005","article-title":"Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases","volume":"108","author":"Andersson","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2026.125182_bb0035","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.13121","article-title":"Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects","volume":"41","author":"Jenkins","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2026.125182_bb0040","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/apt.13461","article-title":"Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis","volume":"43","author":"Ashida","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jchromb.2026.125182_bb0045","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/gutjnl-2015-311304","article-title":"Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for helicobacter pylori eradication: a phase III, randomised, double-blind study","volume":"65","author":"Murakami","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jchromb.2026.125182_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40261-016-0455-2","article-title":"Pharmacokinetic drug\u2013drug interactions between vonoprazan and low-dose aspirin or nonsteroidal anti-inflammatory drugs: a phase 2, open-label study in healthy Japanese men","volume":"37","author":"Sakurai","year":"2017","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jchromb.2026.125182_bb0055","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/CIRCULATIONAHA.108.191087","article-title":"ACCF\/ACG\/AHA 2008 Expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use","volume":"118","author":"Bhatt","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jchromb.2026.125182_bb0060","first-page":"2619","article-title":"ACCF\/ACG\/AHA 2010 Expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update","volume":"122","author":"Abraham","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jchromb.2026.125182_bb0065","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jchromb.2026.125182_bb0070","first-page":"1347","article-title":"Chromatographic assay of recently approved co-formulation of vonoprazan fumarate with low-dose aspirin: AGREE, complex MoGAPI, and RGB 12-model assessments","volume":"18","author":"Abdel Moneim","year":"2024","journal-title":"BMC Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0075","article-title":"Nano-scale analytical insights for determination of vonoprazan and aspirin in a recently approved combined preparation utilizing nucleophilic substitution reaction","volume":"193","author":"El-Masry","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/j.jchromb.2026.125182_bb0080","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jaoacint\/qsac128","article-title":"Spectrophotometric quantitative analysis of aspirin and vonoprazan fumarate in recently approved fixed-dose combination tablets","volume":"106","author":"Abdelazim","year":"2023","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jchromb.2026.125182_bb0085","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/bmc.2694","article-title":"Review of HPLC methods and HPLC methods with mass spectrometric detection for direct determination of aspirin with its metabolite(s) in various biological matrices","volume":"26","author":"Mullangi","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2026.125182_bb0090","doi-asserted-by":"crossref","first-page":"597","DOI":"10.4103\/0250-474X.36958","article-title":"RP-HPLC analysis of aspirin and clopidogrel bisulphate in combination","volume":"69","author":"Anandakumar","year":"2007","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125182_bb0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/0250-474X.119816","article-title":"Stability-indicating HPLC method for simultaneous determination of aspirin and prasugrel","volume":"75","author":"Patel","year":"2013","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125182_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0250-474X.89753","article-title":"Development and validation of a reversed-phase HPLC method for simultaneous determination of aspirin, atorvastatin calcium and clopidogrel bisulphate in capsules","volume":"73","author":"Londhe","year":"2011","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125182_bb0105","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/bmc.1386","article-title":"Development and validation of a high-performance liquid chromatography method for the simultaneous determination of aspirin and folic acid from nano-particulate systems","volume":"24","author":"Chaudhary","year":"2010","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2026.125182_bb0110","first-page":"438","article-title":"HPLC method for the simultaneous estimation of aspirin and omeprazole in their new combination","volume":"7","author":"Nassar","year":"2017","journal-title":"Anal. Sci."},{"key":"10.1016\/j.jchromb.2026.125182_bb0115","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1021\/jf950458y","article-title":"Determination of acetylsalicylic acid and salicylic acid in foods using HPLC with fluorescence detection","volume":"44","author":"Venema","year":"1996","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0120","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/chromsci\/bmv043","article-title":"Isolation, characterization of a potential degradation product of aspirin and an HPLC method for quantitative estimation of its impurities","volume":"53","author":"Acharya","year":"2015","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2026.125182_bb0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1874383800802010019","article-title":"Stability-indicating spectrofluorimetric and RP-HPLC methods for the determination of aspirin and dipyridamole in their combination","volume":"2","author":"Hammud","year":"2008","journal-title":"Open Spectrosc. J."},{"key":"10.1016\/j.jchromb.2026.125182_bb0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.17576\/mjas-2016-2002-05","article-title":"Stability-indicating RP-HPLC method for simultaneous determination of aspirin and clopidogrel in dosage form","volume":"20","author":"Gousuddin","year":"2016","journal-title":"Malays. J. Anal. Sci."},{"key":"10.1016\/j.jchromb.2026.125182_bb0135","first-page":"48","article-title":"Stability-indicating HPLC method for the simultaneous quantification of aspirin and pravastatin in bulk and tablets","volume":"7","author":"Athota","year":"2017","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2026.125182_bb0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/chrsci\/49.2.165","article-title":"Simultaneous determination of clopidogrel and aspirin by RP-HPLC from bulk material and dosage formulations using multivariate calibration technique","volume":"49","author":"Sultana","year":"2011","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jchromb.2026.125182_bb0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.trac.2013.04.010","article-title":"The 12 principles of green analytical chemistry and the SIGNIFICANCE mnemonic of green analytical practices, TrAC","volume":"50","author":"Ga\u0142uszka","year":"2013","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0150","article-title":"Green analytical chemistry","author":"Koel","year":"2010","journal-title":"R. Soc. Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0155","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: green analytical procedure index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2026.125182_bb0160","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/analytica5030030","article-title":"Modified GAPI (MoGAPI) tool and software for the assessment of method greenness","volume":"5","author":"Mansour","year":"2024","journal-title":"Analytica"},{"key":"10.1016\/j.jchromb.2026.125182_bb0165","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0170","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1039\/D3GC02347H","article-title":"Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality","volume":"25","author":"Manousi","year":"2023","journal-title":"Green Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2021.116223","article-title":"White analytical chemistry: an approach to reconcile the principles of green analytical chemistry and functionality","volume":"138","author":"Nowak","year":"2021","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0185","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trac.2017.10.028","article-title":"\u2018Quality by design\u2019 approach for the analysis of impurities in pharmaceutical drug products and drug substances, TrAC","volume":"101","author":"Dispas","year":"2018","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0190","series-title":"Q2(R1) validation of analytical procedures: Text and methodology, in: ICH Quality Guidelines, Elsevier, Amsterdam","first-page":"127","author":"Borman","year":"2017"},{"key":"10.1016\/j.jchromb.2026.125182_bb0195","first-page":"111","article-title":"Simultaneous determination of 11 drugs belonging to four different groups in human urine samples by reversed-phase high-performance liquid chromatography method","volume":"632","author":"Baranowska","year":"2009","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2026.125182_bb0200","first-page":"569","article-title":"Stability-indicating chromatographic determination of aspirin and omeprazole in their binary mixture","volume":"87","author":"Taha","year":"2004","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jchromb.2026.125182_bb0205","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0378-4347(00)80270-4","article-title":"Determination of aspirin and its major metabolites in plasma by high-performance liquid chromatography without solvent extraction","volume":"225","author":"Rumble","year":"1981","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.jchromb.2026.125182_bb0210","first-page":"25","article-title":"Development of a stability\u2013indicating HPLC method for simultaneous determination of ten related substances in vonoprazan fumarate drug substance","volume":"150","author":"Luo","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2026.125182_bb0215","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/jssc.201501154","article-title":"Identification, characterization, and high-performance liquid chromatography quantification of process-related impurities in vonoprazan fumarate","volume":"39","author":"Liu","year":"2016","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2026.125182_bb0220","article-title":"A novel fast analytical method for the determination of N-nitroso vonoprazan in vonoprazan tablets and raw materials using LC-ESI-MS\/MS","author":"Abuothman","year":"2024","journal-title":"Int. J. Environ. Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/sscp.202400118","article-title":"Liquid chromatography\u2013mass spectrometry method for determination of N-methyl-N-nitrosopyridin-4-amine in a vonoprazan fumarate drug","volume":"7","author":"Chilukuri","year":"2024","journal-title":"Sep. Sci. Plus"},{"key":"10.1016\/j.jchromb.2026.125182_bb0230","unstructured":"International Council for Harmonisation (ICH), ICH Harmonised Guideline Q2(R2): Validation of Analytical Procedures, Final version, adopted on 1 November 2023. 2026 Available at: https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q2(R2)_Guideline_2023_1130.pdf Source."},{"key":"10.1016\/j.jchromb.2026.125182_bb0250","author":"Stat-Ease Inc"},{"key":"10.1016\/j.jchromb.2026.125182_bb0255","series-title":"Paper Presentation, International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human use, Geneva, Switzerland","article-title":"Stability testing of new drug substances and products Q1A(R2)","author":"ICH(Q1A)","year":"2003"},{"key":"10.1016\/j.jchromb.2026.125182_bb0260","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: green analytical procedure index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"issue":"3","key":"10.1016\/j.jchromb.2026.125182_bb0265","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/analytica5030030","article-title":"Modified GAPI (MoGAPI) tool and software for the assessment of method greenness: case studies and applications","volume":"5","author":"Mansour","year":"2024","journal-title":"Analytica"},{"key":"10.1016\/j.jchromb.2026.125182_bb0270","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1039\/D1GC02318G","article-title":"Complementary green analytical procedure index (ComplexGAPI) and software","volume":"23","author":"P\u0142otka-Wasylka","year":"2021","journal-title":"Green Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0275","article-title":"A total scoring system and software for complex modified GAPI (ComplexMoGAPI) application in the assessment of method greenness","volume":"4","author":"Mansour","year":"2024","journal-title":"Green Anal. Chem."},{"issue":"14","key":"10.1016\/j.jchromb.2026.125182_bb0280","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116553","article-title":"AGREEprep\u2013analytical greenness metric for sample preparation","volume":"149","author":"Wojnowski","year":"2022","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","article-title":"Analytical eco-scale for assessing the greenness of analytical procedures, TrAC","volume":"37","author":"Ga\u0142uszka","year":"2012","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0290","doi-asserted-by":"crossref","first-page":"7598","DOI":"10.1039\/D3GC02347H","article-title":"Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality","volume":"25","author":"Manousi","year":"2023","journal-title":"Green Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0315","article-title":"Click analytical chemistry index as a novel concept and framework, supported with open source software to assess analytical methods","volume":"14","author":"Mansour","year":"2025","journal-title":"Adv. Sample Prep."},{"key":"10.1016\/j.jchromb.2026.125182_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.greeac.2023.100056","article-title":"How to evaluate methods used in chemical laboratories in terms of the total chemical risk?\u2014a ChlorTox scale","volume":"5","author":"Nowak","year":"2023","journal-title":"Green Anal. Chem."},{"key":"10.1016\/j.jchromb.2026.125182_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.greeac.2023.100065","article-title":"ChlorTox Base\u2014a useful source of information on popular reagents in terms of chemical hazards and greenness assessment","volume":"6","author":"Nowak","year":"2023","journal-title":"Green Anal. Chem."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226002710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023226002710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:24:29Z","timestamp":1785515069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023226002710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":58,"alternative-id":["S1570023226002710"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125182","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stability-indicating RP-HPLC\u2013DAD method for aspirin and vonoprazan using analytical quality by design and comprehensive greenness assessment","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2026.125182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"125182"}}